US2012136387A1PendingUtilityA1

Photochemical tissue bonding

45
Assignee: REDMOND ROBERT WPriority: Feb 11, 2000Filed: Sep 23, 2011Published: May 31, 2012
Est. expiryFeb 11, 2020(expired)· nominal 20-yr term from priority
A61B 2017/005A61F 2009/00887A61L 24/001A61F 9/008A61F 2009/00853A61F 2009/00872A61B 2017/00508A61B 2017/00517A61F 9/00821A61F 9/0081A61L 27/50
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Photochemical tissue bonding methods include the application of a photosensitizer to a tissue and/or tissue graft, followed by irradiation with electromagnetic energy to produce a tissue seal. The methods are useful for tissue adhesion, such as in wound closure, tissue grafting, skin grafting, musculoskeletal tissue repair, ligament or tendon repair and corneal repair.

Claims

exact text as granted — not AI-modified
1 - 17 . (canceled) 
     
     
         18 . A method for grafting tissue, comprising:
 contacting a first tissue, a second tissue comprising a tissue graft, and at least one photosensitizer agent to form a tissue-photosensitizer complex; and   applying electromagnetic energy to the tissue-photosensitizer complex in a manner effective to bond the tissue,   wherein the tissue is not contacted with an exogenous protein or peptide which is cross linked by the application of electromagnetic energy, thereby creating a tissue seal between the first and second tissue.   
     
     
         19 . The method of  claim 18 , wherein the first tissue is selected from the group consisting of cardiovascular, neurological, gastrointestinal, renal, urological, occular, oral, respiratory, otolaryngological, dermatological, gynecological, genital and connective tissue. 
     
     
         20 . The method of  claim 18 , wherein the tissue is skin. 
     
     
         21 . The method of  claim 18 , wherein the at least one photosensitizer agent is selected from the group consisting of a xanthene, flavin and pyridine. 
     
     
         22 . The method of  claim 21 , wherein the xanthene is Rose Bengal. 
     
     
         23 . The method of  claim 21 , wherein the flavin is riboflavin-5-phosphate. 
     
     
         24 . The method of  claim 21 , wherein the pyridine is N-hydroxypyridine-2-(1H)-thione 
     
     
         25 . The method of  claim 18 , wherein the contacting steps occurs ex vivo. 
     
     
         26 . The method of  claim 18 , wherein the contacting steps occurs in vivo in a subject. 
     
     
         27 . The method of  claim 26 , wherein the subject is a human. 
     
     
         28 . The method of  claim 18 , wherein the application of electromagnetic energy to the tissue-photosensitizer complex occurs without substantial thermal tissue damage. 
     
     
         29 . The method of  claim 18 , wherein the application of electromagnetic energy to the tissue-photosensitizer complex occurs without more than a 15° C. rise in temperature. 
     
     
         30 . The method of  claim 18 , wherein the application of electromagnetic energy to the tissue-photosensitizer complex occurs without more than a 10° C. rise in temperature. 
     
     
         31 . The method of  claim 18 , wherein the application of electromagnetic energy to the tissue-photosensitizer complex occurs without more than a 3° C. rise in temperature. 
     
     
         32 . The method of  claim 18 , wherein the electromagnetic energy applied is less than 2000 J/cm 2 . 
     
     
         33 . The method of  claim 18 , wherein the electromagnetic energy is applied at an irradiance less than 1.5 W/cm 2 . 
     
     
         34 . The method of  claim 18 , wherein the electromagnetic energy is applied at an irradiance of about 0.60 W/cm 2 . 
     
     
         35 - 82 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.